ENDRA Life Sciences, Inc. (NDRA)
4.80
+0.02
(+0.42%)
USD |
NASDAQ |
Oct 23, 16:00
4.80
0.00 (0.00%)
After-Hours: 20:00
ENDRA Life Sciences Net Income (Quarterly) : 0.1599M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1599M |
| March 31, 2026 | -1.311M |
| December 31, 2025 | -3.169M |
| September 30, 2025 | -1.596M |
| June 30, 2025 | -1.226M |
| March 31, 2025 | -1.036M |
| December 31, 2024 | -4.149M |
| September 30, 2024 | -2.354M |
| June 30, 2024 | -2.229M |
| March 31, 2024 | -2.776M |
| December 31, 2023 | -1.460M |
| September 30, 2023 | -3.101M |
| June 30, 2023 | -2.557M |
| March 31, 2023 | -2.943M |
| December 31, 2022 | -3.290M |
| September 30, 2022 | -3.440M |
| June 30, 2022 | -3.591M |
| March 31, 2022 | -2.858M |
| December 31, 2021 | -3.105M |
| September 30, 2021 | -2.658M |
| June 30, 2021 | -3.199M |
| Date | Value |
|---|---|
| March 31, 2021 | -2.269M |
| December 31, 2020 | -2.251M |
| September 30, 2020 | -3.258M |
| June 30, 2020 | -2.894M |
| March 31, 2020 | -3.323M |
| December 31, 2019 | -4.809M |
| September 30, 2019 | -3.414M |
| June 30, 2019 | -2.334M |
| March 31, 2019 | -2.749M |
| December 31, 2018 | -2.366M |
| September 30, 2018 | -2.759M |
| June 30, 2018 | -1.847M |
| March 31, 2018 | -2.825M |
| December 31, 2017 | -2.295M |
| September 30, 2017 | -0.9089M |
| June 30, 2017 | -1.432M |
| March 31, 2017 | -0.7416M |
| December 31, 2016 | -0.6869M |
| September 30, 2016 | -0.9799M |
| December 31, 2015 | -0.4587M |
| September 30, 2015 | -0.541M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Accuray, Inc. | -1.941M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -15.80M |
| ResMed, Inc. | 383.43M |
| Rockwell Medical, Inc. | -1.172M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -0.1599M |
| EPS Diluted (Quarterly) | 0.1208 |
| Enterprise Value | 2.088M |
| Earnings Yield | -131.6% |
| Normalized Earnings Yield | -126.98 |